Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

NCT03633331 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Estrogen Receptor-positive Breast Cancer
HER2/Neu Negative
Stage IV Breast Cancer AJCC v6 and v7

Interventions

DRUG: Palbociclib
DRUG: Letrozole
DRUG: Fulvestrant
OTHER: Questionnaire Administration
OTHER: Quality-of-Life Assessment

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]